longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

HUALAN BIOLOGICAL

002007

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 28.79, within the reasonable range, cheaper than 48.69% of the time in the past 5 years, and the industry ranks 12/85, the industry Median 11.59.

28.79xP/E
¥12.74Stock price
¥0.44Earnings per share
28.79xP/E
Stock price¥12.74Earnings per share¥0.44

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
28.53x
Typical range
23.84x–33.80x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.59x
03978117156

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.59x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
603087SHGan & Lee
35.83x24.52%¥41.19B
002252SZShanghai RAAS
26.46x16.67%¥31.97B
300896SZIMEIK
24.55x2.02%¥26.88B
600161SHBTBP
31.42x6.67%¥23.79B
002007SZHUALAN BIOLOGICAL
28.79x4.14%¥23.26B
301301SZYili Chuanning Bio
29.99x20.59%¥17.75B
000403SZPLBIO
35.49x213.64%¥9.50B
300406SZBSBE
29.13x121.88%¥6.55B
300841SZKanghua Biological
26.12x22.92%¥6.44B
002880SZWEIGUANG BIOLOGICAL
25.57x20.82%¥4.68B
603739SHVland Biotech
37.59x25.00%¥3.07B
300653SZZHBIO
37.73x20.65%¥2.62B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.